Why G3139 works poorly in cancer trials but might work well against HIV.

Abstract

The antisense drug G3139 (oblimersen sodium, Genta, Inc.) is a phosphorothioate oligodeoxynucleotide (ODN) containing unmethylated CpG units, which is targeted to suppress Bcl-2. To date, its effectiveness in cancer clinical trials has been minimal. Some suggestions are provided for that disappointment and recent citations are provided that support the idea that G3139 may be effective at clearing viral infections, specifically HIV. At the time G3139 was conceived as an anti-cancer drug candidate, it was viewed optimistically because Bcl-2 was widely believed to be the most important protein blocking p53-dependent apoptosis caused by internal stress. Since that time, we have learnt that Bcl-2 is not the only protein that inhibits apoptosis and that p53 itself is frequently malfunctioning in tumors. Thus, the anti-cancer utility of suppressing Bcl-2 in cancer cells is limited. Moreover, Bcl-2 has a role in halting the cell cycle (though p27), which may slow down tumor growth; and Bcl-2 even has pro-apoptotic roles in the execution of apoptosis initiated by external death signals (via Fas/CD95 and caspase 3). Overall, in the clinical setting, G3139 usually has statistically significant but medically unimportant benefit. These results have greatly diminished the enthusiasm for the drug especially when the side effects are considered. Specifically, the unmethylated CpG ODN (and/or the phosphorothioate group) activates the immune system, but this potentially important anti-cancer effect is lost when the immune cells undergo premature apoptosis apparently because their Bcl-2 levels have been lowered by the antisense effect of G3139. While this effect on immune cells is usually undesirable, it is exactly what would be useful for activating immune cells, initiating provirus transcription in retrovirus-infected cells, and facilitating selective apoptosis of these infected cells. In general, G3139 might have benefit in clearing chronic infections by intracellular parasites including viruses (HIV, SIV, HTLV, HBV, coronavirus, etc.). Indeed, G3139 has been shown to cause apoptosis in EBV-infected cells leading to clearance of the virus.

• Authors: George E Parris
• Journal: Medical hypotheses (Med Hypotheses) Vol. 69 Issue 3 Pg. 537-40 ( 2007) ISSN: 0306-9877 [Print] United States
• PMID: 17363184 (Publication Type: Journal Article)

Chemical References

• Anti-HIV Agents
• Oligonucleotides, Antisense
• Proto-Oncogene Proteins c-bcl-2
• Thionucleotides
• oblimersen

Topics

• Animals
• Anti-HIV Agents (therapeutic use)
• Apoptosis
• Clinical Trials as Topic
• Genes, p53
• HIV Infections (therapy)
• Humans
• Immune System
• Models, Biological
• Mutation
• Neoplasms (therapy)
• Oligonucleotides, Antisense (therapeutic use)
• Proto-Oncogene Proteins c-bcl-2 (genetics)
• Thionucleotides (therapeutic use)
• Treatment Outcome